Ricky Kamdem-ouaffo, Trading AS Kamdem Group v. Naturasource International LLC et al.

Case Overview & Background

This patent infringement appeal involves a pro se inventor, Dr. Ricky Kamdem-ouaffo, against major players in the consumer products and pet food industries: Colgate-Palmolive Co. and its subsidiary, Hill's Pet Nutrition Inc., along with Naturasource International LLC and its principal, Laszlo Pokorny. Dr. Kamdem-ouaffo, a food scientist operating as Kamdem Group, is an individual inventor enforcing his own patents. The defendants are large, well-established operating companies; Colgate-Palmolive is a multinational consumer products company, and Hill's Pet Nutrition is a leading global brand in the specialty pet food market. Naturasource International is a smaller entity that appears to have been involved in a prior development relationship with the inventor. This long-running dispute centers on technology Dr. Kamdem-ouaffo allegedly disclosed to the defendants for use in pet food, which he now claims infringes his subsequently issued patents.

The accused products are pet foods, specifically those sold by Hill's Pet Nutrition, that possess antimicrobial properties. Dr. Kamdem-ouaffo alleges these products incorporate technology he invented and patented. While the specific patents asserted in the most recent district court complaint are not detailed in the available appellate record, they relate generally to methods of using natural plant extracts, such as hops beta acids, to inhibit microbial growth and improve the safety and shelf-life of pet food compositions. This dispute originated not as a patent case, but as a state court action for trade secret misappropriation, breach of contract, and fraud, which was decided against Dr. Kamdem-ouaffo. He later secured patents on the technology and filed a new suit for patent infringement in the U.S. District Court for the District of New Jersey.

The case is now before the U.S. Court of Appeals for the Federal Circuit on appeal from the District of New Jersey's dismissal of the patent infringement action. The district court, siding with the defendants, dismissed the case with prejudice on the grounds of claim preclusion (res judicata), finding that the patent claims were based on the same underlying facts and transactions as the prior, failed trade secret litigation. The appeal is notable not for its direct technological or industry impact, but as an example of the significant procedural hurdles faced by inventors in disputes with large corporations, particularly concerning the intersection of trade secret and patent law. The core issue on appeal is whether a claim for patent infringement is legally distinct from a prior claim for trade secret misappropriation, even when both relate to the same technology and disclosure event.

Key Legal Developments and Outcome

The patent litigation between Ricky Kamdem-ouaffo and the defendants is the culmination of over a decade of legal battles, primarily litigated in New Jersey state and federal courts. The current appeal to the Federal Circuit, designated as a "patent infringement" action, follows a series of unsuccessful lawsuits by Mr. Kamdem-ouaffo focused on trade secret misappropriation and fraud related to the defendants' patent applications for pet food technology. Due to the plaintiff's extensive and repetitive litigation history, the key developments are marked by motions to dismiss based on preclusion doctrines rather than typical patent litigation milestones like claim construction or trial.

Chronological Developments:

• 2013-08-20 – Initial State Court Action & Federal Removal: Mr. Kamdem-ouaffo first sued the defendants in New Jersey state court (No. MID-L-5527-13), alleging various state-law claims related to the misappropriation of his pet food formula ideas. After defendants moved for summary judgment in 2015, Mr. Kamdem-ouaffo filed a notice of removal to the U.S. District Court for the District of New Jersey.

  • 2015-09-29 – Remand to State Court: The district court granted the defendants' motion to remand the case back to state court, finding a lack of federal subject-matter jurisdiction. This removal and remand action was docketed as D.N.J., No. 3:15-cv-06290. The state court subsequently granted summary judgment to the defendants and dismissed the action "in its entirety with prejudice."
  • 2015-12-04 – Attorney's Fees Awarded: In the federal removal action (15-cv-06290), the district court awarded attorney's fees and costs to the defendants, totaling over $14,000, due to the improper removal. This fee award was later appealed by Mr. Kamdem-ouaffo to the Third Circuit, which affirmed the award in a July 2017 opinion (No. 16-2304).

• 2015-11-04 – Second Federal Lawsuit (15-cv-07902): Undeterred by the remand, Mr. Kamdem-ouaffo filed a new, separate lawsuit in the District of New Jersey, again raising claims related to the same underlying dispute.

  • Motion to Dismiss: The defendants moved to dismiss, arguing the new claims were barred by the doctrines of res judicata (claim preclusion) and collateral estoppel (issue preclusion) from the now-concluded state court case, as well as the Rooker-Feldman doctrine, which prevents federal district courts from reviewing state court judgments.
  • Dismissal with Prejudice: The district court ultimately dismissed Mr. Kamdem-ouaffo's third amended complaint with prejudice, agreeing with the defendants that the claims were barred. This dismissal was appealed to the Third Circuit.
  • 2022-02-08 – Third Circuit Affirmance (21-1198): The U.S. Court of Appeals for the Third Circuit affirmed the district court's dismissal, holding that the claims were plainly barred by preclusion principles. The court noted, "This very dispute, however, had already resolved against Kamdem-Ouaffo in New Jersey state court."

• 2022-11-14 – Third Federal Lawsuit (22-cv-06623): Mr. Kamdem-ouaffo initiated yet another lawsuit in the District of New Jersey, alleging fraud on the court and violations of the Defend Trade Secrets Act, among other claims, against the original defendants as well as their law firms and the state court judge from the original action.

  • 2023-10-31 – Dismissal with Prejudice: The district court granted the defendants' motions to dismiss, finding the claims were time-barred and, once again, an improper attempt to relitigate previously decided issues.
  • 2024-07-01 – Third Circuit Affirmance (23-2982): The Third Circuit again affirmed the dismissal, describing the lawsuit as Mr. Kamdem-ouaffo's "fourth attempt to relitigate his claims in federal court following his state court loss." Mr. Kamdem-ouaffo subsequently petitioned the U.S. Supreme Court for a writ of certiorari, which was denied.

• 2026-04-08 – Judgment in Original Removal Action: Recent court records indicate that a final judgment or order was entered in the original 2015 federal case (D.N.J., No. 3:15-cv-06290), which had been primarily concerned with the remand and attorney's fees. The specific nature of this judgment is not detailed in available public records, but its timing immediately precedes the appeal to the Federal Circuit.

• 2026-04-21 – Appeal to the Federal Circuit (26-1708): Mr. Kamdem-ouaffo filed a notice of appeal to the U.S. Court of Appeals for the Federal Circuit. The appeal is captioned Ricky Kamdem-ouaffo v. Naturasource International LLC et al., and docket information characterizes the nature of the suit as "Patent Infringement." This appeal is presumably from the April 8, 2026 judgment.

Parallel PTAB Proceedings:
There is no public record of any parallel proceedings before the Patent Trial and Appeal Board (PTAB), such as Inter Partes Review (IPR) or Post-Grant Review (PGR), related to this dispute. The conflict has centered on Mr. Kamdem-ouaffo's allegations of improper inventorship on the defendants' patent applications, not on challenging the validity of an issued patent.

Current Posture & Outcome:
The litigation is currently an open appeal before the Federal Circuit (No. 26-1708). Mr. Kamdem-ouaffo is proceeding pro se. Given the extensive history of prior dismissals on preclusion grounds in other federal courts, a central issue on appeal will likely be jurisdictional—both whether the Federal Circuit is the proper venue for this appeal and whether the underlying district court claims are barred by res judicata and collateral estoppel from the prior state and federal court judgments.

To date, Mr. Kamdem-ouaffo has been unsuccessful in all his adjudicated federal and state actions against these defendants. No court has found merit in his claims of misappropriation or fraud. The case has not progressed to substantive patent litigation stages such as claim construction, fact discovery on infringement, or trial.

Plaintiff Representatives

The plaintiff, Dr. Ricky Kamdem-ouaffo, is representing himself in this appeal before the Federal Circuit. This is consistent with his conduct in numerous prior related proceedings in federal district and appellate courts, where he has consistently litigated without legal counsel.

• Name: Ricky Kamdem-ouaffo, Ph.D.
• Role: Plaintiff-Appellant, Pro Se
• Firm: N/A (Trading as Kamdem Group)
• Note: "Pro se" is a Latin term meaning "for oneself," and it indicates that a party to a lawsuit is not represented by an attorney. Dr. Kamdem-ouaffo has an extensive history as a pro se litigant, including in multiple appeals to the U.S. Court of Appeals for the Third Circuit and a petition for a writ of certiorari to the U.S. Supreme Court, all related to the same underlying dispute. Court documents from these prior cases explicitly identify him as appearing "pro se."

Defendant Representatives

As the appeal to the Federal Circuit (No. 26-1708) was filed on April 21, 2026, formal appearances of counsel for the defendants-appellees may not yet be recorded in the public docket. However, based on their consistent and recent representation of the defendants in the underlying district court cases and related Third Circuit appeals, the following attorneys are the anticipated counsel of record.

Two distinct legal teams have represented the two sets of defendants throughout this long-running dispute.

For Colgate-Palmolive Co. and Hill's Pet Nutrition Inc.:

• Liza M. Walsh (Lead Counsel)

  • Firm: Connell Foley LLP (Newark, NJ)
  • Note: A former federal judge for the District of New Jersey and accomplished trial attorney, Walsh has extensive experience in complex commercial and intellectual property litigation.

• Tricia B. O'Reilly (Of Counsel)

  • Firm: Connell Foley LLP (Newark, NJ)
  • Note: O'Reilly is a partner in the firm's commercial litigation group and has worked alongside Liza Walsh on this matter in prior federal proceedings.

For Naturasource International LLC and Laszlo Pokorny:

• William C. Baton (Lead Counsel)

  • Firm: Saul Ewing LLP (Newark, NJ)
  • Note: Baton is a partner in the firm's Intellectual Property practice with a focus on patent litigation, including significant experience in high-stakes pharmaceutical and Hatch-Waxman Act cases.

• Charles F. Rysavy (Of Counsel)

  • Firm: Saul Ewing LLP (Newark, NJ)
  • Note: Rysavy is counsel in the firm's IP and commercial litigation groups and has consistently appeared with William Baton in prior related federal cases on behalf of Naturasource and Pokorny.